ALS gene therapy (CHUV)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameALS gene therapy (CHUV)
Drug Alias Nameamyotrophic lateral sclerosis gene therapy (CHUV)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionApoptosis regulator Bcl-2 stimulants
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre Hospitalier Universitaire Vaudois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of ZurichCentre Hospitalier Universitaire Vaudois
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A